{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T23:23:35Z","timestamp":1794266615496,"version":"4.9.0"},"reference-count":32,"publisher":"American Medical Association (AMA)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Oncol"],"published-print":{"date-parts":[[2020,5,1]]},"DOI":"10.1001\/jamaoncol.2020.0147","type":"journal-article","created":{"date-parts":[[2020,3,26]],"date-time":"2020-03-26T11:46:34Z","timestamp":1585223194000},"page":"650","source":"Crossref","is-referenced-by-count":1134,"title":["Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer"],"prefix":"10.1001","volume":"6","author":[{"given":"Ryan","family":"Phillips","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William Yue","family":"Shi","sequence":"additional","affiliation":[{"name":"Stanford Cancer Institute, Department of Radiation Oncology, School of Medicine, Stanford University, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Deek","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noura","family":"Radwan","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su Jin","family":"Lim","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel S.","family":"Antonarakis","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven P.","family":"Rowe","sequence":"additional","affiliation":[{"name":"The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland"},{"name":"The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley E.","family":"Ross","sequence":"additional","affiliation":[{"name":"The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Gorin","sequence":"additional","affiliation":[{"name":"The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland"},{"name":"The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Curtiland","family":"Deville","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen C.","family":"Greco","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailun","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel R.","family":"Denmeade","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Channing J.","family":"Paller","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirl","family":"Dipasquale","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodore L.","family":"DeWeese","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland"},{"name":"Department of Medical Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland"},{"name":"The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel Y.","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland"},{"name":"Department of Medical Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland"},{"name":"The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Carducci","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth J.","family":"Pienta","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland"},{"name":"The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin G.","family":"Pomper","sequence":"additional","affiliation":[{"name":"The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland"},{"name":"The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam P.","family":"Dicker","sequence":"additional","affiliation":[{"name":"Sidney Kimmel Cancer Center, Department of Radiation Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario A.","family":"Eisenberger","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ash A.","family":"Alizadeh","sequence":"additional","affiliation":[{"name":"Stanford Cancer Institute, Division of Oncology, Department of Medicine, School of Medicine, Stanford University, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian","family":"Diehn","sequence":"additional","affiliation":[{"name":"Stanford Cancer Institute, Department of Radiation Oncology, School of Medicine, Stanford University, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phuoc T.","family":"Tran","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland"},{"name":"Department of Medical Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland"},{"name":"The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"5","key":"coi200004r2","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1097\/JU.0000000000000117","article-title":"Targeting metastatic hormone sensitive prostate cancer: chemohormonal therapy and new combinatorial approaches.","volume":"201","author":"Damodaran","year":"2019","journal-title":"J Urol"},{"issue":"1","key":"coi200004r3","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.eururo.2018.03.028","article-title":"Update on systemic prostate cancer therapies: management of metastatic castration-resistant prostate cancer in the era of precision oncology.","volume":"75","author":"Nuhn","year":"2019","journal-title":"Eur Urol"},{"issue":"1","key":"coi200004r4","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1200\/JCO.1995.13.1.8","article-title":"Oligometastases.","volume":"13","author":"Hellman","year":"1995","journal-title":"J Clin Oncol"},{"issue":"1","key":"coi200004r5","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2017.3501","article-title":"Consolidative radiotherapy for limited metastatic non\u2013small-cell lung cancer: a phase 2 randomized clinical trial.","volume":"4","author":"Iyengar","year":"2018","journal-title":"JAMA Oncol"},{"issue":"18","key":"coi200004r6","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1200\/JCO.19.00201","article-title":"Local consolidative therapy vs maintenance therapy or observation for patients with oligometastatic non\u2013small-cell lung cancer: long-term results of a multi-institutional, phase II, randomized study.","volume":"37","author":"Gomez","year":"2019","journal-title":"J Clin Oncol"},{"issue":"10185","key":"coi200004r7","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1016\/S0140-6736(18)32487-5","article-title":"Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial.","volume":"393","author":"Palma","year":"2019","journal-title":"Lancet"},{"issue":"10162","key":"coi200004r8","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1016\/S0140-6736(18)32486-3","article-title":"Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial.","volume":"392","author":"Parker","year":"2018","journal-title":"Lancet"},{"issue":"5","key":"coi200004r9","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1200\/JCO.2017.75.4853","article-title":"Surveillance or metastasis-directed therapy for oligometastatic prostate cancer recurrence: a prospective, randomized, multicenter phase II trial.","volume":"36","author":"Ost","year":"2018","journal-title":"J Clin Oncol"},{"issue":"10185","key":"coi200004r10","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1016\/S0140-6736(19)30278-8","article-title":"SABR-COMET: harbinger of a new cancer treatment paradigm.","volume":"393","author":"Loo","year":"2019","journal-title":"Lancet"},{"issue":"12","key":"coi200004r11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028650","article-title":"MicroRNA expression characterizes oligometastasis(es).","volume":"6","author":"Lussier","year":"2011","journal-title":"PLoS One"},{"issue":"12","key":"coi200004r12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0050141","article-title":"Oligo- and polymetastatic progression in lung metastasis(es) patients is associated with specific microRNAs.","volume":"7","author":"Lussier","year":"2012","journal-title":"PLoS One"},{"issue":"6","key":"coi200004r13","doi-asserted-by":"publisher","first-page":"3540","DOI":"10.18632\/oncotarget.v6i6","article-title":"14q32-Encoded microRNAs mediate an oligometastatic phenotype.","volume":"6","author":"Uppal","year":"2015","journal-title":"Oncotarget"},{"issue":"1","key":"coi200004r14","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1038\/s41467-018-04278-6","article-title":"Integrated molecular subtyping defines a curable oligometastatic state in colorectal liver metastasis.","volume":"9","author":"Pitroda","year":"2018","journal-title":"Nat Commun"},{"issue":"12","key":"coi200004r15","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1158\/2159-8290.CD-17-0716","article-title":"Early detection of molecular residual disease in localized lung cancer by circulating tumor DNA profiling.","volume":"7","author":"Chaudhuri","year":"2017","journal-title":"Cancer Discov"},{"issue":"4","key":"coi200004r16","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1136\/gutjnl-2017-315852","article-title":"Serial circulating tumour DNA analysis during multimodality treatment of locally advanced rectal cancer: a prospective biomarker study.","volume":"68","author":"Tie","year":"2019","journal-title":"Gut"},{"issue":"12","key":"coi200004r17","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djx118","article-title":"Concordance of circulating tumor DNA and matched metastatic tissue biopsy in prostate cancer.","volume":"109","author":"Wyatt","year":"2017","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"coi200004r18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0195149","article-title":"Classification for long-term survival in oligometastatic patients treated with ablative radiotherapy: a multi-institutional pooled analysis.","volume":"13","author":"Hong","year":"2018","journal-title":"PLoS One"},{"issue":"32","key":"coi200004r19","doi-asserted-by":"publisher","first-page":"3240","DOI":"10.1200\/JCO.18.00847","article-title":"The 46th David A. Karnofsky Memorial Award Lecture: oligometastasis\u2014from conception to treatment.","volume":"36","author":"Weichselbaum","year":"2018","journal-title":"J Clin Oncol"},{"issue":"12","key":"coi200004r20","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1038\/s41591-018-0232-2","article-title":"Radiotherapy induces responses of lung cancer to CTLA-4 blockade.","volume":"24","author":"Formenti","year":"2018","journal-title":"Nat Med"},{"issue":"4","key":"coi200004r21","doi-asserted-by":"publisher","first-page":"194","DOI":"10.2310\/7200.2006.023","article-title":"How to randomize.","volume":"4","author":"Vickers","year":"2006","journal-title":"J Soc Integr Oncol"},{"issue":"8","key":"coi200004r22","doi-asserted-by":"publisher","first-page":"4078","DOI":"10.1118\/1.3438081","article-title":"Stereotactic body radiation therapy: the report of AAPM Task Group 101.","volume":"37","author":"Benedict","year":"2010","journal-title":"Med Phys"},{"issue":"23","key":"coi200004r23","doi-asserted-by":"publisher","first-page":"11428","DOI":"10.1073\/pnas.1902651116","article-title":"Genomic correlates of clinical outcome in advanced prostate cancer.","volume":"116","author":"Abida","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"coi200004r24","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1158\/2159-8290.CD-17-0937","article-title":"Circulating tumor DNA genomics correlate with resistance to abiraterone and enzalutamide in prostate cancer.","volume":"8","author":"Annala","year":"2018","journal-title":"Cancer Discov"},{"issue":"5","key":"coi200004r25","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.eururo.2016.11.033","article-title":"Germline mutations in ATM and BRCA1\/2 distinguish risk for lethal and indolent prostate cancer and are associated with early age at death.","volume":"71","author":"Na","year":"2017","journal-title":"Eur Urol"},{"issue":"7547","key":"coi200004r26","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/nature14347","article-title":"The evolutionary history of lethal metastatic prostate cancer.","volume":"520","author":"Gundem","year":"2015","journal-title":"Nature"},{"issue":"4","key":"coi200004r27","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.eururo.2018.12.042","article-title":"Circulating tumor DNA abundance and potential utility in de novo metastatic prostate cancer.","volume":"75","author":"Vandekerkhove","year":"2019","journal-title":"Eur Urol"},{"issue":"6","key":"coi200004r28","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/S1470-2045(16)00107-8","article-title":"Timing of androgen-deprivation therapy in patients with prostate cancer with a rising PSA (TROG 03.06 and VCOG PR 01-03 [TOAD]): a randomised, multicentre, non-blinded, phase 3 trial.","volume":"17","author":"Duchesne","year":"2016","journal-title":"Lancet Oncol"},{"issue":"3","key":"coi200004r29","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1097\/01.ju.0000113794.34810.d0","article-title":"Early versus delayed hormonal therapy for prostate specific antigen only recurrence of prostate cancer after radical prostatectomy.","volume":"171","author":"Moul","year":"2004","journal-title":"J Urol"},{"issue":"12","key":"coi200004r30","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1200\/JCO.2005.04.7423","article-title":"Immediate or deferred androgen deprivation for patients with prostate cancer not suitable for local treatment with curative intent: European Organisation for Research and Treatment of Cancer (EORTC) trial 30891.","volume":"24","author":"Studer","year":"2006","journal-title":"J Clin Oncol"},{"issue":"7","key":"coi200004r31","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/S1470-2045(15)00054-6","article-title":"Local radiotherapy and granulocyte-macrophage colony-stimulating factor to generate abscopal responses in patients with metastatic solid tumours: a proof-of-principle trial.","volume":"16","author":"Golden","year":"2015","journal-title":"Lancet Oncol"},{"issue":"1","key":"coi200004r32","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.ijrobp.2018.08.066","article-title":"Patterns of progression after 68Ga-PSMA-ligand PET\/CT-guided radiation therapy for recurrent prostate cancer.","volume":"103","author":"Soldatov","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"coi200004r1","unstructured":"Surveillance, Epidemiology, and End Results Program. Cancer stat facts: prostate cancer. Accessed January 28, 2020. https:\/\/seer.cancer.gov\/statfacts\/html\/prost.html"}],"container-title":["JAMA Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/articlepdf\/2763312\/jamaoncology_phillips_2020_oi_200004.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T23:07:37Z","timestamp":1589497657000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/fullarticle\/2763312"}},"subtitle":["The ORIOLE Phase 2 Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2020,5,1]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaoncol.2020.0147","relation":{},"ISSN":["2374-2437"],"issn-type":[{"value":"2374-2437","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5,1]]}}}